• Mashup Score: 0

    Treatment with ultrahigh-dose methylcobalamin may slow the functional decline of amyotrophic lateral sclerosis patients with early-stage disease and a moderate progression rate, indicate Japanese trial data published in JAMA Neurology. This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.

    Tweet Tweets with this article
    • You have to read this one carefully -- https://t.co/3WAVYPhyxH Also, the b12 theories have been around for a long time. Google is your friend.